Clinical Trials Logo

Clinical Trial Summary

Primary objective: To evaluate compliance of LoFric Origo in a general intermittent catheterization (IC) population with the use of LoFric Origo, by means of a subjective assessment scale

Secondary objectives:

- To evaluate the subject's perception associated with the use of the LoFric Origo, by means of a subjective assessment scale

- To evaluate the subject's discomfort associated with the use of the LoFric Origo, by means of a subjective assessment scale

- To observe and collect data on bladder regimen/IC frequency by assessments of descriptive data of demography, catheter therapy, history and other patient reported outcomes.

Study Design: Non-interventional study, multicentre, prospective study. Target Subject Population: General intermittent catheterization, LoFric Origo male users.

Medical Device: LoFric Origo

Study Variable(s):

- Primary variable: Use or No use of LoFric Origo after 8 weeks.

- Secondary variable(s): patient reported questionnaire with regards to perception, discomfort, diagnose, health status, catheter history and other patient reported outcomes.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01796587
Study type Observational
Source Wellspect HealthCare
Contact
Status Completed
Phase N/A
Start date January 2013

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06429631 - The Effect of CIC Education on QOL and Compliance With Mobile Application in Individuals With Spinal Cord Injury. N/A
Recruiting NCT03353571 - A Prospective Evaluation of the Catheter Science C3 "Umbrella Catheter." N/A